Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
Hansoh Pharmas Zolbetuximab Receives BLA Acceptance for Gastric Cancer Treatment in China
>> article
Hansoh Pharmas Zolbetuximab Receives BLA Acceptance for Gastric Cancer Treatment in China
Editor:xuezhe Clicks:
0
Date:2023-9-1 15:10:15
Keyword:
Hansoh Pharma
Healthoo Information:
Hansoh Pharmas Zolbetuximab Receives BLA Acceptance for Gastric Cancer Treatment in China
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
The overhaul of Northeast Pharmaceutical came to an end in the summer ...
Technical transformation project of Jilin Beisha Pharmaceutical Co., L...
The project of NCPC Characteristic Synthetic Drug Base started, the fi...
Cellulose Ether Market Analysis: Pharmaceutical Industrys Growth Trend
Nine key words & hot events in the pharmaceutical industry in 2023 H1
Changes of global supply chain pattern of pharmaceutical products befo...
$161 million! China Biopharmaceutical completes acquisition of F-star ...
Shandong Jingxin Pharmaceutical Co., Ltd. has entered the stage of equ...
Is the class solidified? From Biotech to Pharma
Nicolas Pharmaceutical, the life death bureau of innovative drug paten...
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
